Masaki Y, Kawabata H, Takai K, Tsukamoto N, Fujimoto S, Ishigaki Y, et al. 2019 Updated diagnostic criteria and disease severity classification for TAFRO syndrome. Int J Hematol. 2020;111:155–8.
Takai K, Nikkuni K, Shibuya H, Hashidate H. Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly. Rinsho Ketsueki. 2010;51:320–5.
Masaki Y, Arita K, Sakai T, Takai K, Aoki S, Kawabata H. Castleman disease and TAFRO syndrome. Ann Hematol. 2022;101:485–90.
Article CAS PubMed PubMed Central Google Scholar
Nishimura Y, Faigenbaum DC, Pierson SK, et al. Validated international definition of the TAFRO clinical subtype of idiopathic multicentric Castleman disease. Am J Hematol. 2021;96(10):1241–52.
Article PubMed PubMed Central Google Scholar
Fujimoto S, Sakai T, Kawabata H, Kurose N, Yamada S, Takai K, et al. Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease? Am J Hematol. 2019;94:975–83.
Article CAS PubMed Google Scholar
Kawabata H, Fujimoto S, Sakai T, et al. Patient’s age and D-dimer levels predict the prognosis in patients with TAFRO syndrome. Int J Hematol. 2021;114:179–88.
Article CAS PubMed PubMed Central Google Scholar
van Rhee F, Voorhees P, Dispenzieri A, et al. International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. Blood. 2018;132(20):2115–24.
Article PubMed PubMed Central Google Scholar
Allegra A, Rotondo F, Russo S, et al. Castleman-Kojima disease (TAFRO syndrome) in a Caucasian patient: a rare case report and review of the literature. Blood Cells Mol Dis. 2015;55(3):206–7.
Iwasaki T, Kuragano T, et al. TAFRO syndrome with renal biopsy successfully treated with steroids and cyclosporine: a case report. BMC Nephrol. 2022;23:262.
Article PubMed PubMed Central Google Scholar
Watanabe M, Haji Y, Hozumi M, et al. Combined B-cell immunomodulation with rituximab and belimumab in severe, refractory TAFRO syndrome associated with Sjögren’s syndrome: A case report. Mod Rheumatol Case Rep. 2023;7(2):475–9.
Yin X, Liu Y, Zhong C, et al. Rituximab-bortezomib-dexamethasone induce high response rates in iMCD in clinical practice. Br J Haematol. 2023;203(5):803–6.
Article CAS PubMed Google Scholar
Kakutani T, Nunokawa T, Chinen N, et al. Treatment-resistant idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever, reticulin fibrosis, renal dysfunction, and organomegaly managed with Janus kinase inhibitors: a case report. Medicine. 2022;101(48): e32200.
Article PubMed PubMed Central Google Scholar
Pierson SK, Lim MS, Srkalovic G, Brandstadter JD, Sarmiento Bustamante M, Shyamsundar S, et al. Treatment consistent with idiopathic multicentric Castleman disease guidelines is associated with improved outcomes. Blood Adv. 2023;7(21):6652–64.
Article CAS PubMed PubMed Central Google Scholar
van Rhee F, Voorhees P, Dispenzieri A, Fosså A, Srkalovic G, Ide M, et al. International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. Blood. 2018;132(20):2115–24.
Article PubMed PubMed Central Google Scholar
Dispenzieri A, Fajgenbaum DC. Overview of Castleman disease. Blood. 2020;135(16):1353–64.
Sakaki A, Hosoi H, Kosako H, et al. Successful combination treatment with rituximab, steroid pulse therapy, plasma exchange and romiplostim for very severe TAFRO syndrome. Leuk Lymphoma. 2022;63(10):2499–502.
Article CAS PubMed Google Scholar
Iwaki N, Fajgenbaum DC, Nabel CS, Gion Y, Kondo E, Kawano M, et al. Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric castleman disease. Am J Hematol. 2016;91:220–6.
Article CAS PubMed Google Scholar
José FF, Kerbauy LN, Perini GF, Blumenschein DI, Pasqualin DDC, Malheiros DMAC, et al. A life-threatening case of TAFRO syndrome with dramatic response to tocilizumab, rituximab, and pulse steroids: the first case report in Latin America. Medicine. 2017;96: e6271.
Article PubMed PubMed Central Google Scholar
Ozeki T, Tsuji M, Yamamoto J, Shigematsu C, Maruyama S. Thrombotic microangiopathy on kidney biopsy in a patient with TAFRO syndrome. CEN Case Rep. 2018;7:243–7.
Article PubMed PubMed Central Google Scholar
Mizuno H, Sekine A, Oguro M, Oshima Y, Kawada M, Sumida K, et al. Renal histology in a patient with TAFRO syndrome: a case report. Hum Pathol. 2018;82:258–63.
Noda-Narita S, Sumida K, Sekine A, Hoshino J, Mise K, Suwabe T, et al. TAFRO syndrome with refractory thrombocytopenia responding to tocilizumab and romiplostim: a case report. CEN Case Rep. 2018;7:162–8.
Article PubMed PubMed Central Google Scholar
Nakamori A, Akagaki F, Yamaguchi Y, Arima R, Sugiura T. Nephrotic syndrome with thrombocytopenia, lymphadenopathy, systemic inflammation, and splenomegaly. Intern Med. 2018;57:1123–9.
Tanaka M, Tsujimoto H, Yamamoto K, Shimoda S, Oka K, Takeoka H. Clinicopathological features of progressive renal involvement in TAFRO syndrome: a case report and literature review. Medicine. 2017;96: e8216.
Article PubMed PubMed Central Google Scholar
Mizuno H, Sawa N, Watanabe S, et al. The clinical and histopathological feature of renal manifestation of TAFRO syndrome. Kidney Int Rep. 2020;5:1172–9.
Article PubMed PubMed Central Google Scholar
Furuto Y, Hashimoto H, et al. Membranoproliferative glomerulonephritis-like finding for TAFRO syndrome, associated with an anterior mediastinal tumor. Medicine. 2018;97(24):e11057.
Leurs A, Gnemmi V, Terriou L, et al. Renal pathologic findings in TAFRO syndrome: is there a continuum between thrombotic microangiopathy and membranoproliferative glomerulonephritis? A case report and literature review. Front Immunol. 2019:10:1489.
Saito H, Tanaka K, Kazama J, et al. Pathological finding of progressive renal involvement in a patient with TAFRO syndrome. CEN case report. 2019;8:239–45.
Nagayama Y, Yamato M, Matsui K, et al. TAFRO syndrome as a cause of glomerular microangiopathy: a case report and literature review. BMC Nephrol. 2019;20:375.
Article PubMed PubMed Central Google Scholar
Simeni Njonnou SR, Deuson J, et al. Unexplained cause of thrombocytopenia, fever, anasarca and hypothyroidism: TAFRO syndrome with thrombotic microangiopathy renal histology. BMJ Case Report. 2020;13:e234155.
Zhou Q, Xhang Y, et al. Kidney biopsy findings in two patients with TAFRO syndrome: case presentations and review of the literature. BMC Nephrol. 2020;21(1):499.
Article PubMed PubMed Central Google Scholar
Shimada K, Sasaki T, Okabe M, et al. TAFRO syndrome with kidney involvement: a case series of patients with kidney biopsies. Kidney Med. 2021;2:286–93.
Nakayama Y, Mizuno H, Ubara Y, et al. Adolescent-onset TAFRO syndrome with malignant nephrosclerosis-like lesions. Intern Med. 2023;62:2223–9.
Sato H, Kanno A, Fukukawa K, et al. Case report: acase of TAFRO syndrome with severe and prolonged thrombocytopenia: diagnostic pitfalls. Front Immunol. 2023;14:1266187.
Article CAS PubMed PubMed Central Google Scholar
Naomi S, Takashi Y, Kensuke T, Hiruta H, Tomoaki MA, Ichiro T. A case of tafro syndrome who showed remarkable elevation of presepsin level without an apparent infectious disease. J Jpn Soc Lab Med. 2022;70:29–34.
留言 (0)